Consumption Of Yerba Mate ( Ilex Paraguariensis ) Improves Serum Lipid Parameters In Healthy Dyslipidemic Subjects And Provides An Additional LDL-cholesterol Reduction In Individuals On Statin Therapy
|Trial Length||1-6 months|
|Number of Subjects||102|
|Age Range||45-64, 65+|
|Body Types||Obese, Overweight|
3 servings of yerba tea (330mL) per day for 40 days, in a population of people on statin therapy already.
Yerba Mate was able to lower LDL cholesterol by 8.7% in normolipidemic persons, 8.1-8.6% in dyslipidemics (at 20 and 40 days, respectively).
Non-HDL lipoproteins decreased, and HDL increased by 4.4%. Apolipoprotein B was also found to be significantly reduced by 6%.
All measured effects were slightly more potent in hypercholesterolemic persons.